Published By: Syndicate Market Research
Noninvasive Prenatal Testing (NIPT) Market Global industry Perspective, Comprehensive
Analysis and Forecast, 2014 - 2020
3422 SW 15 Street, Suit #8138,
Florida 33442, USA
Toll Free: 1-855-465-4651
Noninvasive Prenatal Testing (NIPT) Market
Noninvasive prenatal testing (NIPT) is also known as noninvasive prenatal diagnosis (NIPD). Noninvasive prenatal testing (NIPT) market is used for screening pregnant women at high risk of developing
fetal chromosomal aneuploidies such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome)
and trisomy 13 (Patau syndrome) or a sex chromosome irregularity, such as Turner syndrome. The
testing can also be used to determine a baby's sex and rhesus (Rh) blood type. The Non-Invasive
Prenatal Test (NIPT) is a DNA test on maternal blood to screen for the fetal aneuploidies (chromosomes
21, 18, 13) during pregnancy. Now, noninvasive prenatal testing is only available for women who have
certain risk issue. Non-invasive prenatal testing (NIPT) offers harmony, verifi, Panorama, informaSeq,
VisibiliT, PrenaTest, BambniTest and other test.
The NIPT market is growing, due to rising healthcare expenditure. The common maternal age is rising in
high income countries, owing to varying pattern of employment, education and marriage and growing
price of raising a child. The increase in common maternal age is resulting in the development of the
global NIPT market. The exponential growth of the NIPT market is supported by factors such as high
birth rate with Down syndrome, no risk of miscarriage with NIPT, and shifting trend toward child bearing
at advanced maternal age.
Browse the full "Noninvasive Prenatal Testing (NIPT) Market -Global industry Perspective,
Comprehensive Analysis and Forecast, 2014 - 2020" report at...